Johnson and Johnson to acquire heart pump maker Abiomed in $16bn deal

Corporate Finance

Johnson and Johnson to acquire heart pump maker Abiomed in $16bn deal

Download PDF Introduction On November 1 Johnson & Johnson, an American multinational which develops medical devices and is ranked 36 in the fortune 500 companies with yearly sales of $98.3bn, announced its proposal to acquire AbioMmed [ABMD: NASDAQ], a cardiovascular technology group. The acquisition, worth $16.6bn, will make Johnson & Read more…

By BSIC, 1 year1 year ago

Corporate Finance

Germany IPO Market skyrockets as Siemens spins off its medtech division

Siemens AG (ETR: SIE) – market cap as of 06/04/2018: €88.8bn Siemens Healthineers AG (ETR: SHL) – market cap as of 06/04/2018: €33.9bn Introduction On March 16, 2018, the German conglomerate Siemens performed an initial public offering of its principal and second most profitable division, Healthineers, on the Frankfurt Stock Read more…

By BSIC, 6 years ago

Medtech

Corporate Finance